NeuroVasc Announces First Patient Enrolled in ENVI™-SR Mechanical Thrombectomy System Clinical Trial in China

Pivotal trial will assess use of the device for blood clot removal in strokes IRVINE, Calif.--(BUSINESS WIRE)--NeuroVasc Technologies, Inc. today announced that the first patient has been treated in a Chinese Pivotal Randomized Controlled Trial to eva...

Full "IntellAsia: Resources" article